​Ares Capital: High Yield in Private Equity

MoneyShow  |

Ares Capital (ARCC) invests in the debt and equity of privately held companies. Its management keeps a sharp eye on its loan portfolio, explains income expert Jack Adamo, editor of Insiders Plus


Witness that loan losses, or nonaccruing loans, are just 0.9% of the fair value of its portfolio. Assurance that attention to loan quality will remain acute is the fact that insiders own 1.9 million shares, which is a fair number for a firm its size.


Further faith in the company's loan portfolio comes from the fact that 91% of it is floating-rate, while Ares’ funding is 82% fixed and only 18% floating. Bottom line? Management has locked in rates on their liabilities but will benefit from the uptick in interest rates. Moreover, the loan-to-value ratio of its portfolio is 54%, not 80-95%, as typically seen in mortgage lending.

As a result of its efforts, Ares has also earned an investment-grade credit rating of BBB. The company invests primarily in noncyclical businesses with attractive growth prospects and high free cash flow. It avoids volatile industries like retailing and mining and is cautious on oil and gas. About 21% of the portfolio is health care, 19% is business services, and 7% is consumer products.

The stock is a dividend play. The $0.38 per quarter dividend yields 9.6%. The dividend may vary quarter to quarter, but $0.30 is the lowest it has been since 2004 when it was listed. Recall that many companies slashed dividends brutally during the 2008 crash.

Not Ares. Recent dividend coverage is 124%, and as interest rates go up, so will Ares' earnings. Oh, I almost forgot to mention. The stock's trailing P/E was under 12. That's the kind of value we're always looking for.

Ares is a Business Development Company. Like a REIT, it has a pass-through tax structure. It must distribute at least 90% of its taxable income as dividends to investors. That means its probably taxed as ordinary income, not dividends. Check with your tax advisor. You may have a higher net return if you put it in an IRA.

The stock was recently featured in Barron’s; given Ares’ relatively small float and the thirst for income these days, this one could get out of hand. So be careful and don't buy with a market order.

Jack Adamo is editor of Jack Adamo’s Insiders Plus.

Subscribe to Jack Adamo's Insiders Plus here…

About MoneyShow.com: Founded in 1981, MoneyShow is a privately held financial media company headquartered in Sarasota, Florida. As a global network of investing and trading education, MoneyShow presents an extensive agenda of live and online events that attract over 75,000 investors, traders and financial advisors around the world.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content